시장보고서
상품코드
1985050

의료 미생물학 검사 기술 시장 보고서(2026년)

Medical Microbiology Testing Technology Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

의료 미생물학 검사 기술 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 60억 달러에서 2026년에는 65억 달러로, CAGR 8.2%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장 요인으로는 감염 발생률 증가, 항균제 내성에 대한 인식 증가, 의료비 증가, 임상검사실 확대, 자동화 시스템 도입 확대 등을 꼽을 수 있습니다.

의료 미생물학 검사 기술 시장 규모는 향후 수년간 강력한 성장이 전망되고 있습니다. 2030년에는 88억 2,000만 달러에 달하며, CAGR은 8.0%에 달할 전망입니다. 예측 기간 중의 성장은 신속 검사 및 현장 검사에 대한 수요증가, 정부 주도 구상 및 공중 보건 프로그램 확대, 식품 및 의약품 안전 검사에 대한 관심 증가, 신흥 시장에서의 확장, 검사 정보 시스템 통합의 진전에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 분자진단의 발전, 고처리량 검사 플랫폼의 혁신, 다중 검사 및 신속 진단 검사의 개발, 미생물학 분야의 연구개발 활성화, 혈청학 및 면역학 검사와의 기술 통합 등을 들 수 있습니다.

신속한 병원체 감지 및 식별에 대한 수요증가는 향후 수년간 의료용 미생물 검사 기술 시장의 성장을 촉진할 것으로 예측됩니다. 신속한 병원체 검출 및 동정은 장기간의 배양 과정 없이 임상 검체에서 박테리아, 바이러스, 기타 병원체 등의 미생물을 신속하고 정확하게 식별하는 진단 기술을 사용합니다. 이를 통해 진단까지의 시간이 단축되어 보다 신속한 임상적 판단이 가능해집니다. 전 세계 공중보건 시스템 및 임상 실험실에서 검사 결과 보고 시간을 단축하고, 전염병 유행과 증가하는 약물 내성 문제에 효과적에 대응하기 위해 노력하면서 신속 검출에 대한 수요가 증가하고 있습니다. 의료 미생물학 검사 기술은 첨단 진단 방법을 통해 감염 요인을 신속하고 정확하게 식별하여 적시에 치료하고 감염 확산을 억제함으로써 병원균의 신속한 검출을 돕습니다. 예를 들어 2025년 11월, 일본에 본부를 둔 공중보건 기관인 감염병 감시센터에 따르면 2025년 4월 데이터에 따르면 단일 보고 기간 중 병원체 범주별로 2,104건에서 2,153건의 호흡기 병원체 검사가 실시되었으며, 중증급성호흡기증후군 코로나바이러스 2(SARS(SARS-CoV-2), 인플루엔자, 호흡기세포융합바이러스, 폐렴구균의 양성률은 5.7%에서 11.5%에 달했습니다. 따라서 병원균의 신속한 검출 및 식별에 대한 수요증가는 의료용 미생물 검사 기술 시장의 확대에 기여하고 있습니다.

의료 미생물학 검사 기술 시장에서 활동하는 주요 기업은 연구 효율성 향상, 검출 정확도 향상, 공중 보건 모니터링 강화를 위해 디지털 PCR(dPCR) 분석과 같은 첨단 분자 분석 솔루션 개발에 주력하고 있습니다. 디지털 PCR 분석은 매우 낮은 농도에서도 특정 DNA 염기서열을 검출 및 정량할 수 있는 고감도 기술로, 이를 통해 병원균의 정확한 동정 및 모니터링이 가능합니다. 예를 들어 2024년 6월 네덜란드에 본사를 둔 분자생물학 및 생명과학 솔루션 프로바이더인 QIAGEN N.V.(QIAGEN N.V.)는 자사의 QIAcuity 디지털 PCR 플랫폼용 습식 실험실 검증을 거친 35개의 새로운 디지털 PCR 미생물 DNA 검출 분석법을 발표했습니다. QIAGEN의 GeneGlobe 연구 플랫폼을 통해 제공되는 이 분석은 뎅기열, 치쿤구니야열, 말라리아 등 열대성 질환과 성병(STI) 및 요로감염증(UTI)을 유발하는 다양한 병원체를 표적으로 삼을 수 있도록 설계되었습니다.

자주 묻는 질문

  • 의료 미생물학 검사 기술 시장 규모는 어떻게 변화하고 있나요?
  • 의료 미생물학 검사 기술 시장의 성장 요인은 무엇인가요?
  • 의료 미생물학 검사 기술 시장에서의 주요 동향은 무엇인가요?
  • 신속한 병원체 감지 및 식별의 중요성은 무엇인가요?
  • 의료 미생물학 검사 기술 시장에서 활동하는 주요 기업은 어디인가요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.04.13

Medical microbiology testing technology refers to the application of specialized laboratory methods and instruments used to detect, identify, and analyze microorganisms such as bacteria, viruses, fungi, and parasites. It involves examining clinical samples to understand microbial characteristics, behavior, and interactions. This technology supports accurate diagnosis and monitoring of infectious diseases by providing precise and reliable testing results.

The primary product types of medical microbiology testing technology include reagents, instruments, consumables, software, and services. Reagents are chemical or biological substances used to detect or quantify microorganisms such as bacteria, viruses, fungi, and parasites using culture methods, PCR, immunoassays, and DNA sequencing. Technologies include cell culture, microscopy, and serology. Applications include infectious disease diagnostics, non-infectious disease testing, R&D, and clinical trials, serving hospitals, diagnostic labs, pharmaceutical companies, research institutes, and the food and beverage industry.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the medical microbiology testing technology market by increasing costs of imported reagents, analytical instruments, optical components, and electronic modules used in laboratory testing systems. diagnostic laboratories and hospitals in north america and europe are most affected due to dependence on imported equipment, while asia-pacific faces higher production costs for exported instruments. these tariffs are raising operational expenses and slowing laboratory upgrades. at the same time, they are supporting domestic manufacturing of reagents, local instrument assembly, and regional supply chain strengthening.

The medical microbiology testing technology market research report is one of a series of new reports from The Business Research Company that provides medical microbiology testing technology market statistics, including medical microbiology testing technology industry global market size, regional shares, competitors with a medical microbiology testing technology market share, detailed medical microbiology testing technology market segments, market trends and opportunities, and any further data you may need to thrive in the medical microbiology testing technology industry. This medical microbiology testing technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical microbiology testing technology market size has grown strongly in recent years. It will grow from $6.00 billion in 2025 to $6.50 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing incidence of infectious diseases, growing antimicrobial resistance awareness, rising healthcare expenditure, expansion of clinical laboratories, increasing adoption of automated systems.

The medical microbiology testing technology market size is expected to see strong growth in the next few years. It will grow to $8.82 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to rising demand for rapid and point-of-care testing, growing government initiatives and public health programs, increasing focus on food and pharmaceutical safety testing, expansion in emerging markets, rising integration of laboratory information systems. Major trends in the forecast period include advancements in molecular diagnostics, innovations in high-throughput testing platforms, developments in multiplex and rapid diagnostic tests, increasing research and development in microbiology, technological integration with serological and immunological testing.

The increasing demand for rapid pathogen detection and identification is expected to drive the growth of the medical microbiology testing technology market in the coming years. Rapid pathogen detection and identification involve the use of diagnostic technologies that quickly and accurately identify microorganisms such as bacteria, viruses, and other pathogens directly from clinical samples without prolonged culture processes, thereby reducing time to diagnosis and enabling faster clinical decision-making. The demand for rapid detection is rising as public health systems and clinical laboratories worldwide seek to improve turnaround times and respond more effectively to infectious disease outbreaks and growing antimicrobial resistance challenges. Medical microbiology testing technology supports rapid pathogen detection by enabling the swift and accurate identification of infectious agents through advanced diagnostic approaches, helping ensure timely treatment and limit the spread of infections. For example, in November 2025, according to the Infectious Disease Surveillance Center, a Japan-based public health organization, data from April 2025 showed that between 2,104 and 2,153 respiratory pathogen tests were performed per pathogen category during a single reporting period, with positivity rates for severe acute respiratory syndrome coronavirus 2, influenza, respiratory syncytial virus, and parainfluenza ranging from 5.7% to 11.5%. Therefore, the growing demand for rapid pathogen detection and identification is contributing to the expansion of the medical microbiology testing technology market.

Major companies operating in the medical microbiology testing technology market are concentrating on the development of advanced molecular analysis solutions, such as digital PCR (dPCR) assays, to improve research efficiency, increase detection accuracy, and strengthen public health surveillance. Digital PCR assays are highly sensitive technologies capable of detecting and precisely quantifying specific DNA sequences, even at extremely low concentrations, thereby enabling accurate pathogen identification and monitoring. For example, in June 2024, QIAGEN N.V., a Netherlands-based provider of molecular biology and life sciences solutions, introduced 35 new wet-lab validated digital PCR Microbial DNA Detection Assays for its QIAcuity digital PCR platform. These assays are accessible through QIAGEN's GeneGlobe research platform and are designed to target a broad spectrum of pathogens responsible for tropical diseases such as dengue, chikungunya, and malaria, as well as sexually transmitted infections (STIs) and urinary tract infections (UTIs).

In June 2025, bioMerieux S.A., a France-based provider of in vitro diagnostics solutions, acquired Day Zero Diagnostics for approximately $25 million. Through this acquisition, bioMerieux sought to enhance its next-generation sequencing (NGS) capabilities and expand its rapid diagnostics portfolio to more effectively address antibiotic-resistant infections and improve the management of life-threatening infectious diseases. Day Zero Diagnostics is a US-based diagnostic company developing sequencing-based microbiology testing technology that enables rapid identification of pathogens and antimicrobial resistance profiles directly from clinical samples.

Major companies operating in the medical microbiology testing technology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Becton Dickinson and Company, bioMerieux SA, Hologic Inc., Sysmex Corporation, Bruker Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Abbott Laboratories, Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Seegene Inc., Oxford Nanopore Technologies plc, Molbio Diagnostics Pvt. Ltd., Hardy Diagnostics, HiMedia Laboratories Pvt. Ltd., Accelerate Diagnostics Inc., Liofilchem S.r.l.

North America was the largest region in the medical microbiology testing technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical microbiology testing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical microbiology testing technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical microbiology testing technology market consists of revenues earned by entities by providing services such as clinical diagnostics, pathogen identification, antimicrobial susceptibility testing, molecular and genetic testing, infection monitoring, outbreak investigation, and laboratory support. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical microbiology testing technology market also includes sales of microbiology analyzers, culture media, reagents and kits, automated identification systems, diagnostic instruments, laboratory consumables, and molecular testing equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Microbiology Testing Technology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical microbiology testing technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical microbiology testing technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical microbiology testing technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Reagents; Instruments; Consumables; Software; Services
  • 2) By Testing Method: Culture Test; Polymerase Chain Reaction; Immunoassays; Deoxyribonucleic Acid Sequence
  • 3) By Technology: Cell Culture; Microscopy; Serology
  • 4) By Application: Infectious Diseases; Non-infectious Diseases; Research And Development; Clinical Trials
  • 5) By End Use: Hospitals; Diagnostic Laboratories; Pharmaceutical Companies; Research Institutes; Food And Beverage Industry
  • Subsegments:
  • 1) By Reagents: Culture Media; Detection Reagents; Antigen And Antibody Reagents; Molecular Diagnostic Kits; Stains And Dyes; Antibiotic Or Susceptibility Testing Reagents
  • 2) By Instruments: Microscopes; Incubators; Automated Culture Systems Or Microbiology Analyzers; Spectrophotometers; Centrifuges; Colony Counters Or Plate Readers; Autoclaves Or Sterilizers; Bioreactors Or Environmental Monitoring Systems
  • 3) By Consumables: Petri Dishes; Test Tubes; Pipette Tips; Microplates; Sample Swabs Or Collection Containers; Slides And Cover Slips; Disposable Filters Or Membranes; Disposable Consumable Kits
  • 4) By Software: Laboratory Information Management Software; Data Analysis Or Result Reporting Software; Quality Control Or Workflow Management Software; Automated Instrument Control Software; Database Or Reference Strain Or Pathogen Registry Software
  • 5) By Services: Contract Testing Or Outsourced Microbiological Testing; Equipment Maintenance And Calibration; Training And Technical Support; Consulting And Compliance Services; Validation And Quality Assurance Services
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Danaher Corporation; Becton Dickinson and Company; bioMerieux SA; Hologic Inc.; Sysmex Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Abbott Laboratories; Meridian Bioscience Inc.; Fujirebio Diagnostics Inc.; Seegene Inc.; Oxford Nanopore Technologies plc; Molbio Diagnostics Pvt. Ltd.; Hardy Diagnostics; HiMedia Laboratories Pvt. Ltd.; Accelerate Diagnostics Inc.; Liofilchem S.r.l.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Medical Microbiology Testing Technology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Medical Microbiology Testing Technology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Medical Microbiology Testing Technology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Medical Microbiology Testing Technology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Field Medical Magnets
    • 4.2.2 Rising Use Of Magnets In Non-Invasive Therapies
    • 4.2.3 Growing Demand For Compact And Wearable Magnetic Devices
    • 4.2.4 Expansion Of Magnet Applications In Neurology Treatments
    • 4.2.5 Enhanced Focus On Precision Magnetic Field Control

5. Medical Microbiology Testing Technology Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Imaging Centers
  • 5.3 Specialty Neurology Centers
  • 5.4 Research And Academic Institutions
  • 5.5 Rehabilitation And Wellness Centers

6. Medical Microbiology Testing Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Microbiology Testing Technology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Medical Microbiology Testing Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Medical Microbiology Testing Technology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Medical Microbiology Testing Technology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Medical Microbiology Testing Technology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Microbiology Testing Technology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Microbiology Testing Technology Market Segmentation

  • 9.1. Global Medical Microbiology Testing Technology Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High-Performance Magnets, Lower-Performance Magnets, Superconducting Magnets, Electromagnets
  • 9.2. Global Medical Microbiology Testing Technology Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neodymium Iron Boron, Ferrite, Samarium Cobalt, Other Materials
  • 9.3. Global Medical Microbiology Testing Technology Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Permanent Magnet Technology, Electromagnetic Systems, Superconducting Magnet Technology, Hybrid Magnetic Systems
  • 9.4. Global Medical Microbiology Testing Technology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Magnetic Resonance Imaging, Transcranial Magnetic Stimulation, Magnetic Therapy, Drug Delivery, Dentistry
  • 9.5. Global Medical Microbiology Testing Technology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Imaging Centers, Specialty Neurology Centers, Research And Academic Institutions, Rehabilitation And Wellness Centers
  • 9.6. Global Medical Microbiology Testing Technology Market, Sub-Segmentation Of High-Performance Magnets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neodymium Iron Boron, Samarium Cobalt, Alnico
  • 9.7. Global Medical Microbiology Testing Technology Market, Sub-Segmentation Of Lower-Performance Magnets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ferrite, Ceramic
  • 9.8. Global Medical Microbiology Testing Technology Market, Sub-Segmentation Of Superconducting Magnets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Niobium Titanium, Niobium Tin, Magnesium Diboride
  • 9.9. Global Medical Microbiology Testing Technology Market, Sub-Segmentation Of Electromagnets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solenoid, Toroidal, Helical

10. Medical Microbiology Testing Technology Market Regional And Country Analysis

  • 10.1. Global Medical Microbiology Testing Technology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Medical Microbiology Testing Technology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Microbiology Testing Technology Market

  • 11.1. Asia-Pacific Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Microbiology Testing Technology Market

  • 12.1. China Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Microbiology Testing Technology Market

  • 13.1. India Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Microbiology Testing Technology Market

  • 14.1. Japan Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Microbiology Testing Technology Market

  • 15.1. Australia Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Microbiology Testing Technology Market

  • 16.1. Indonesia Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Microbiology Testing Technology Market

  • 17.1. South Korea Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Microbiology Testing Technology Market

  • 18.1. Taiwan Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Microbiology Testing Technology Market

  • 19.1. South East Asia Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Microbiology Testing Technology Market

  • 20.1. Western Europe Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Microbiology Testing Technology Market

  • 21.1. UK Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Microbiology Testing Technology Market

  • 22.1. Germany Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Microbiology Testing Technology Market

  • 23.1. France Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Microbiology Testing Technology Market

  • 24.1. Italy Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Microbiology Testing Technology Market

  • 25.1. Spain Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Microbiology Testing Technology Market

  • 26.1. Eastern Europe Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Microbiology Testing Technology Market

  • 27.1. Russia Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Microbiology Testing Technology Market

  • 28.1. North America Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Microbiology Testing Technology Market

  • 29.1. USA Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Microbiology Testing Technology Market

  • 30.1. Canada Medical Microbiology Testing Technology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Microbiology Testing Technology Market

  • 31.1. South America Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Microbiology Testing Technology Market

  • 32.1. Brazil Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Microbiology Testing Technology Market

  • 33.1. Middle East Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Microbiology Testing Technology Market

  • 34.1. Africa Medical Microbiology Testing Technology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Medical Microbiology Testing Technology Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Microbiology Testing Technology Market Regulatory and Investment Landscape

36. Medical Microbiology Testing Technology Market Competitive Landscape And Company Profiles

  • 36.1. Medical Microbiology Testing Technology Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Medical Microbiology Testing Technology Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Medical Microbiology Testing Technology Market Company Profiles
    • 36.3.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Shin-Etsu Chemical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Medical Microbiology Testing Technology Market Other Major And Innovative Companies

  • Canon Medical Systems Corporation, Neo Performance Materials Inc., Ningbo Tongchuang Magnetic Materials Co. Ltd., Stereotaxis Inc., MagnetsTek LLC, SM Magnetics Inc., Zhejiang Zhaobao Magnet Group Co. Ltd., Bunting-DuBois Magnetics, I.M.A. Industria Macchine Automatiche S.p.A., Magnetica Limited, VACUUMSCHMELZE GmbH & Co. KG, Newland Magnetics Europe Ltd., Noveon Magnetics Inc., Goudsmit Magnetics Group B.V., MainRich Magnetics Co. Ltd.

38. Global Medical Microbiology Testing Technology Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Microbiology Testing Technology Market

40. Medical Microbiology Testing Technology Market High Potential Countries, Segments and Strategies

  • 40.1 Medical Microbiology Testing Technology Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Medical Microbiology Testing Technology Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Medical Microbiology Testing Technology Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제